Skip to main content
. 2024 Jun 7;22:546. doi: 10.1186/s12967-024-05263-y

Fig. 6.

Fig. 6

miR-144-3p expression was increased in PBMCs from patients with active TAO. (a) Levels of miR-134-5p, miR-144-3p, miR-431-5p and miR-483-3p in PBMCs determined by RT-PCR and normalized to the U6 expression levels. (b) miR-144-3p-target gene pathway network. Error bars represent the mean ± SD. ns no significance, * p < 0.05, student’s t test. PBMCs peripheral blood mononuclear cells